• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Lenacapavir
    2 Drugs classified under this active ingredient


    All the Active Ingredient Drugs

    Sunlenca solution
    Gilead
    RX
    partial basket chart
    Sunlenca solution

    Antiretrovirals. Lenacapavir 463.5 mg.
    Sol for SC inj. Vials 2 X 463.5 mg in 1.5 ml
    On Day 1 and Day 2, 600 mg Sulenca Tabs. /d taken orally. On Day 8,
    300 mg/d taken orally. Then, on Day 15, 927 mg admin by SC inject. Maint. dose is 927 mg SC inject. every 6 months (26 weeks) from last inject. (+/- 2 weeks).
     In comb. with other antiretroviral(s), for the tmt. of adlts with multidrug resist. HIV-1 infect. for whom it is not possible to constr. a suppress. anti-viral regimen.  
    C/I:Hypersens.
    Co-admin. with strong inducers of CYP3A, P-gp, and UGT1A1, such as: rifampicin/ carbamazepine, phenytoin/
    St. John’s wort (Hypericum perforatum)

    Sunlenca tablets
    Gilead
    RX
    partial basket chart
    Sunlenca tablets

    Antiretrovirals. Lenacapavir 300 mg.
    FC tabs 5 X 300 mg
    On Day 1 and Day 2, 600 mg Sulenca Tabs. /d taken orally. On Day 8,
    300 mg/d taken orally. Then, on Day 15, 927 mg admin by SC inject

    In comb. with other antiretroviral(s), for adlts. with multidrug resist. HIV-1 infect. for whom it is not possible to constr. a suppress. anti-viral regimen, for oral loading prior to admin. of long-acting lenacapavir inject.
    C/I:
     Hypersens. Co-admin. with strong inducers of CYP3A, P-gp, and UGT1A1, such as: rifampicin/ carbamazepine, phenytoin/
    St. John’s wort (Hypericum perforatum)

    CLOSE